Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence-Reference-Cited by-同舟云学术

Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence

Published:2012-04-20 Issue:4 Volume:7 Page:e35262
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nickel Gabrielle C.,Barnholtz-Sloan Jill,Gould Meetha P.,McMahon Sarah,Cohen Andrea,Adams Mark D.,Guda Kishore,Cohen Mark,Sloan Andrew E.,LaFramboise Thomas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Distant metastasis occurs late during the genetic evolution of pancreatic cancer.;S Yachida;Nature,2010

2. The patterns and dynamics of genomic instability in metastatic pancreatic cancer.;PJ Campbell;Nature,2010

3. Tumour evolution inferred by single-cell sequencing.;N Navin;Nature,2011

4. Inferring tumor progression from genomic heterogeneity.;N Navin;Genome Res,2010

5. Cancer statistics, 2010.;A Jemal;CA Cancer J Clin,2010

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening;Cancer Genetics;2024-11

2. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches;International Journal of Molecular Sciences;2024-05-26

3. Scalable co-sequencing of RNA and DNA from individual nuclei;2023-02-10

4. Implications of Chemokine Heterogenicity in Cancer Metastasis;Cytokine and Chemokine Networks in Cancer;2023

5. A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells;Cancers;2022-05-25